MEDI9929
D5240C00001
Phase 2 mab completed
Quick answer
MEDI9929 for Atopic Dermatitis is a Phase 2 program (mab) at MedImmune with 1 ClinicalTrials.gov record(s).
Program details
- Company
- MedImmune
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed